Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonucleotide reductase (RR or RNR) is a crucial enzyme responsible for the de novo synthesis of deoxyribonucleotides from ribonucleotides. This reaction is essential for DNA synthesis and repair in all living organisms, making RR indispensable for cell proliferation and genome stability. Because RR is vital for cell proliferation, it is targeted by several anticancer drugs. Overexpression or dysregulation of certain RR subunits—especially RRM2—is associated with cancer progression and resistance mechanisms.
Inhibition of ribonucleotide reductase, disrupting dNTP supply needed for DNA synthesis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonucleotide Reductase (RR).